|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
SCIDIR_on1164582219 |
| 003 |
OCoLC |
| 005 |
20231120010501.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
200714s2020 sz o 001 0 eng d |
| 040 |
|
|
|a YDX
|b eng
|e pn
|c YDX
|d OPELS
|d OCLCF
|d ABC
|d OCLCO
|d EBLCP
|d OCLCA
|d OCLCO
|d OCLCQ
|d SFB
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 1175912891
|
| 020 |
|
|
|a 9780128200193
|q (electronic bk.)
|
| 020 |
|
|
|a 0128200197
|q (electronic bk.)
|
| 020 |
|
|
|z 0128200189
|
| 020 |
|
|
|z 9780128200186
|
| 035 |
|
|
|a (OCoLC)1164582219
|z (OCoLC)1175912891
|
| 050 |
|
4 |
|a RS189
|
| 082 |
0 |
4 |
|a 615.1901
|2 23
|
| 245 |
0 |
0 |
|a Identification and quantification of drugs, metabolites, drug metabolizing /
|c edited by Shuguang Ma and Swapan K. Chowdhury.
|
| 260 |
|
|
|a Amsterdam :
|b Elsevier,
|c 2020.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Includes index.
|
| 505 |
0 |
|
|a Intro -- Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters: Concepts, Methods, a ... -- Copyright -- Contents -- Contributors -- Foreword -- References -- Preface -- Part I: Techniques for identifying and quantifying drugs and metabolites -- Chapter 1: Bioanalysis of small and large molecule drugs, metabolites, and biomarkers by LC-MS -- 1. Introduction -- 2. Complexity of contemporary bioanalysis -- 3. Bioanalytical requirements for supporting discovery, nonclinical, and clinical studies -- 4. Current regulatory landscape for bioanalysis
|
| 505 |
8 |
|
|a 5. General considerations for bioanalysis for sample collection -- 6. Diagnosis and mitigation of nonspecific adsorption loss for urine bioanalysis -- 7. Tissue bioanalysis -- 8. Managing unstable metabolites such as acyl glucuronide -- 9. General considerations for bioanalysis for extraction, chromatography, and MS detection -- 10. Selected applications for LC-MS bioanalysis -- 10.1. LC-MS of large molecules -- 10.1.1. LC-MS bioanalysis of mAb -- 10.1.2. LC-MS bioanalysis of ADC -- 10.1.3. LC-MS bioanalysis of PDC -- 10.1.4. LC-MS bioanalysis of protein biomarkers
|
| 505 |
8 |
|
|a 10.3.3. Fatty acid amide hydrolase biomarkers (authentic matrix and surrogate analytes) -- 10.4. LC-MS analysis of metabolites and MIST -- 10.4.1. Metabolite quantitation strategy -- 10.4.2. LC-MS bioanalysis of polar metabolites -- 10.4.3. Bioanalysis of chiral compounds -- 10.4.4. Unexpected assay challenge during analysis of patient samples -- 11. Conclusion and future perspective -- References -- Chapter 2: Recent advances in mass spectrometric and other analytical techniques for the identification of drug metabolites -- 1. Introduction -- 2. Sample preparation strategies
|
| 505 |
8 |
|
|a 2.1. Solid-phase extraction -- 2.2. Supported phase liquid extraction -- 2.3. Liquid-liquid extraction -- 2.4. Protein precipitation -- 3. Optical detectors and chromatographic separation techniques -- 3.1. Ultra-performance liquid chromatography -- 3.2. Supercritical fluid chromatography -- 4. Different types of Ionization techniques and mass spectrometric scan functions -- 4.1. Ionization techniques -- 4.2. Mass analyzers and different acquisition modes -- 4.3. Inductively coupled mass spectrometry (ICP-MS) -- 5. Wet chemistry techniques combined with MS
|
| 650 |
|
0 |
|a Drugs
|x Analysis.
|
| 650 |
|
0 |
|a Drugs
|x Metabolism.
|
| 650 |
|
0 |
|a Metabolites.
|
| 650 |
|
0 |
|a Biochemical markers.
|
| 650 |
1 |
2 |
|a Pharmaceutical Preparations
|x analysis
|0 (DNLM)D004364Q000032
|
| 650 |
1 |
2 |
|a Pharmaceutical Preparations
|x metabolism
|0 (DNLM)D004364Q000378
|
| 650 |
2 |
2 |
|a Biomarkers
|0 (DNLM)D015415
|
| 650 |
|
6 |
|a M�edicaments
|x Analyse.
|0 (CaQQLa)201-0036381
|
| 650 |
|
6 |
|a M�edicaments
|x M�etabolisme.
|0 (CaQQLa)201-0046488
|
| 650 |
|
6 |
|a M�etabolites.
|0 (CaQQLa)201-0030193
|
| 650 |
|
6 |
|a Marqueurs biologiques.
|0 (CaQQLa)201-0177920
|
| 650 |
|
7 |
|a Biochemical markers
|2 fast
|0 (OCoLC)fst00831950
|
| 650 |
|
7 |
|a Drugs
|x Analysis
|2 fast
|0 (OCoLC)fst00898769
|
| 650 |
|
7 |
|a Drugs
|x Metabolism
|2 fast
|0 (OCoLC)fst00898845
|
| 650 |
|
7 |
|a Metabolites
|2 fast
|0 (OCoLC)fst01017507
|
| 700 |
1 |
|
|a Ma, Shuguang.
|
| 700 |
1 |
|
|a Chowdhury, Swapan K.
|
| 776 |
0 |
8 |
|i Print version:
|t Identification and quantification of drugs, metabolites, drug metabolizing.
|d Amsterdam : Elsevier, 2020
|z 0128200189
|z 9780128200186
|w (OCoLC)1130251159
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128200186
|z Texto completo
|
